chr1-248650199-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001824.2(OR2T27):c.686G>A(p.Ser229Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00001 in 1,395,672 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001824.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2T27 | NM_001001824.2 | c.686G>A | p.Ser229Asn | missense_variant | 2/2 | ENST00000460972.4 | |
OR2T27 | NM_001386060.1 | c.686G>A | p.Ser229Asn | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2T27 | ENST00000460972.4 | c.686G>A | p.Ser229Asn | missense_variant | 2/2 | NM_001001824.2 | P1 | ||
OR2T27 | ENST00000641652.1 | c.686G>A | p.Ser229Asn | missense_variant | 3/3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD3 exomes AF: 0.0000176 AC: 4AN: 227780Hom.: 0 AF XY: 0.0000245 AC XY: 3AN XY: 122544
GnomAD4 exome AF: 0.0000100 AC: 14AN: 1395672Hom.: 1 Cov.: 32 AF XY: 0.0000130 AC XY: 9AN XY: 694886
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | The c.686G>A (p.S229N) alteration is located in exon 1 (coding exon 1) of the OR2T27 gene. This alteration results from a G to A substitution at nucleotide position 686, causing the serine (S) at amino acid position 229 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at